Pharmacists reviewed and evaluated twice as many patients during the final 4 weeks (1680) compared to the first 4 weeks (834; P\0.0001).
INTRODUCTION
In the management of patients with severe sepsis and septic shock, every hour of delay in the administration of antimicrobial therapy increases mortality by 7.6% [1] . Numerous publications support the timely administration of antimicrobials to assist in the improvement of patient outcomes. The majority of these studies are conducted in patients with severe sepsis and septic shock following the onset of hypotension and demonstrate an increase in in-hospital mortality following a delay in antibiotic administration [1] [2] [3] . Kumar et al. revealed that this ''mortality effect'' is not influenced by a particular bacterial pathogen nor hospital versus community epidemiology and is applicable to large patient population groups. Furthermore, a study conducted across 65 intensive care units (ICUs) analyzing 17,990 septic patients revealed that patient outcomes were negatively impacted regardless of illness severity or hospital location when antimicrobial therapy was delayed [2] . The time elapsed from the written antibiotic order on a paper chart to actual intravenous (IV) administration or 'hang-time' can often be several hours because of work flow logistics within the hospital, the pharmacy department and nursing. Outcome data included the hang-time compliance pre-intervention at baseline (week 1), which was compared to compliance at the end of the study post-intervention (week 60).
Compliance was calculated as the number of timely antibiotic administration leading to better outcomes across a varied spectrum of hospital patients [2] . Additional studies evaluating the timeliness of antimicrobials and impact on outcomes in patients with community-acquired pneumonia and orthopedic surgical procedures supports our initiative's decision not to limit the role of AMS pharmacists' involvement in hang-time interventions to only patients with sepsis or septic shock [8, 9] .
Although not an objective of the study, we were unable to show a significant impact on patient mortality. Reasons for this may include that the appropriateness of antibiotic therapy was not evaluated and all patients reviewed were included in the study, not just those with sepsis and septic shock. Similarly, Ferrer et al.
did not assess antibiotic appropriateness although Kumar and team focused on time to effective antibiotic [1, 2] . Studies also exist that have not established a correlation between the time of the first dose antimicrobial to positive clinical outcomes and decreased mortality. This is evidenced by both Bordon et al. and Chung and Buising when evaluating patients with community-acquired pneumonia, which may suggest that the correct diagnosis and selection of the appropriate agent may have an enhanced influence on patient mortality rather than time of administration [8, 12] .
The increasing rates of MDR organisms and poor compliance with prescribing the appropriate empiric antibiotic in South African hospitals could be additional contributing factors to consider when noting the absence of a difference in patient mortality in our study [13] . This study has highlighted an important additional role for pharmacists in driving AMS 
